Testosterone therapy may ease fatigue in young cancer survivors
NCT ID NCT04049331
First seen Apr 23, 2026 · Last updated May 26, 2026 · Updated 4 times
Summary
This study tests whether testosterone replacement can improve fatigue, sexual function, and quality of life in young male cancer survivors (ages 18-54) who have low testosterone and have been in remission for at least one year. Participants receive either the FDA-approved drug Depo-Testosterone or a placebo. The goal is to see if this treatment helps with cancer-related fatigue and other symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FATIGUE SYNDROME, CHRONIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Veterans Affairs Puget Sound Health Care System
Seattle, Washington, 98108, United States
Conditions
Explore the condition pages connected to this study.